FOOD AND DRUG ADMINISTRATION
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
AGENDA
September 22, 2005
Food and Drug Administration, NIH campus
* FDA Building 29B, Conference Room C
8800 Rockville Pike, Bethesda, MD
1:30 PM EST
1:30 p.m. Call to Order and Opening Remarks Dr. Gary Overturf, Chair
1:35 Announcements/Administrative Matters Christine Walsh, R.N., FDA
Open
Session – Presentation on Laboratory of Retroviruses and Laboratory of
Immunoregulation,
Division of Viral Products; Laboratory of Respiratory &
Special
Pathogens and Laboratory of Methods Development & Quality Control,
Division
of Bacterial Parasitic & Allergenic Products
Overview of Laboratory Dr. Hana Golding, FDA
2:00 Laboratory of Immunoregulation,
Division of Viral Products
Overview of Laboratory Dr. Ira Berkower, FDA
2:20 Laboratory
of Respiratory & Special Pathogens, Division of Bacterial
Parasitic
& Allergenic Products
Overview of Laboratory Dr.
Drusilla L. Burns, FDA
2:40 Laboratory
of Methods Development & Quality Control, Division
of
Bacterial Parasitic & Allergenic Products
Overview of Laboratory Dr. Bruce D. Meade, FDA
3:00 p.m. Open Public Hearing (If
needed, otherwise will move directly to
closed session)
4:00 p.m. Break (Prepare for closed
session)
4:05 p.m. Closed Session
5:05 p.m. Adjourn Meeting
* The public may attend the meeting at the above location where equipment will be provided to allow public participation in the meeting.